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Introduction
Compared with the numerous investigations performed in
the context of postnatal mammary gland development and
carcinogenesis, studies of the early stages of mammary
gland development are much scarcer. Yet several papers
have been published in recent years that shed light on this
phase. I shall review our current state of knowledge of the
signals that regulate early mammary organogenesis.
Morphology of early mammary development
Mammary gland development is initiated during embryonic
life. The first manifestation of the gland in many mammals
is an elevated ridge or milk line, which then fragments into
individual buds in specific regions lateral of the dorsal
midline. These buds are either located in the thoracic
region in primates, in the inguinal area in ungulates or
along the entire length of the trunk in rodents and pigs.
In the mouse embryo the first morphological signs of
mammary rudiments are lens-like placodes that form
around embryonic day 11 and protrude slightly from the
body wall. Within 1 day these placodes grow into bulb-
shaped buds that invaginate the underlying dermis.
Interestingly, growth of the buds is mainly achieved
through cell migration from the epidermis. Rapid cell
proliferation sets in on embryonic day 15 at the tip of the
buds and leads to outgrowth of a primary sprout, which
starts to elongate and bifurcate. These processes create a
small ductal tree at birth that is connected to the skin and
the outside through the nipple. This structure continues to
grow at the same pace as the animal until puberty, when
hormone-dependent development and rapid ductal
elongation and side branching begin.
The surrounding mesenchyme participates in and is also
altered in these processes. As soon as the epithelial bud
forms, concentric layers of mesenchymal cells orient
themselves like a dense halo around the epithelium. These
so-called ‘mammary mesenchyme’ cells are induced by
signals coming from the epithelial cells. When the primary
sprout elongates, it pushes through this sheath of cells
and grows into deeper layers of the dermis toward the
presumptive fat pad, which forms the stroma of the adult
organ. The mammary mesenchyme remains close to the
epidermis and participates in the formation of the nipple
(for an in-depth review of these events, see [1]) (Fig. 1a).
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Molecular events
In evolutionary terms the mammary gland is a rather young
organ. It is thought to be derived from apocrine-like skin
glands of synapsids, which probably served as a source of
moisture for the parchment-shelled eggs and as a source
of nutrients for the hatchlings [2]. The origin of the gland in
close association with feathers and hair is still reflected on
a molecular level. A number of genes are expressed in
hair, whiskers and feathers as well as in the mammary
gland, and deletion of some genes affects development of
all the epidermal appendages. Another common feature of
all skin appendages is the dependence on reciprocal
signals between the epithelium and the mesenchyme (for
a review, see [3,4]).
What are the signals that direct the commitment of a
distinct set of ectoderm cells toward the appendage or,
more specifically, the mammary epithelial fate? The
regional and temporal expression patterns and the results
of targeted gene deletion and overexpression studies have
identified several signaling pathways that are active in the
early stages of bud development and are required for
development of the anlagen (Fig. 1b).
Fibroblast growth factor (FGF) signals play an important
role in many sites of epithelial mesenchymal interactions
and are also involved in mammary bud formation. In the
absence of the FGF receptor FGFR2b or its ligand
FGF10, all but the first inguinal mammary anlagen fail to
develop [5]. Interestingly, in the receptor null mutant the
bud is formed and regresses by apoptosis, while in
FGF10-deficient embryos it is maintained but fails to
undergo branching. While Fgfr2b is expressed in the
mammary placodes from embryonic day 11 onward, the
earliest expression of Fgf10 is detected on embryonic day
15.5 only. Expression of Fgf7 occurs at an earlier stage
and is thought to compensate for the absence of FGF10.
This probably explains the difference in the phenotype of
the mutation of the receptor and the ligand. Trans-
plantation of Fgf10 null epithelia demonstrates that the
requirement for FGF10 extends into the postnatal period.
Mammary ducts develop slower but do not seem to have
any morphological defects, indicating that FGF10 regulates
cell proliferation rather than ductal branching [5].
The first indication for an involvement of wnt signals came
from deletion of the gene encoding the transcription factor
Lef1 [6]. This member of the TCF/LEF family mediates
extracellular wnt signals. It is expressed in mammary
anlagen from embryonic day 11.5 onward. Mammary
placodes are formed in its absence, but their development
is arrested at the early bud stage. Among the many
members of the wnt family, wnt6, wnt 10a and wnt10b
start to be expressed in the surface ectoderm around
embryonic day 11.25, preceding the appearance of
mammary placodes. Interestingly, wnt6 and  wnt10b are
first expressed along a line that seems to define a border
between the dorsal and the ventral body walls. Within
about 36 hours the expression becomes restricted to the
placodes [7].
This expression pattern suggests that formation of the
placodes results from the migration of wnt-expressing
cells along the milk line accompanied by enhanced
expression in the cells that form the placode. In a line of
mice that harbor a transgene that serves as a reporter for
wnt activity on the transcriptional level (TOP-gal),
regionally restricted wnt signals along the milk line have
been confirmed independently (JJ Wysolmerski, personal
communication, 2004). The importance of wnt signaling
is further illustrated by the finding that expression of
Dkk1 (Dickkopf), an inhibitor of wnt signals, in the
mammary anlagen results in an absence of mammary
buds [8].
A naturally occurring spontaneous mutation in the TBX3
gene is the cause of human ulnar mammary syndrome,
which manifests itself in abnormal forelimb and apocrine
gland development [9]. Tbx3 encodes a T-box
transcription factor that is expressed in the mammary bud
Figure 1
Genetic analysis of prenatal mammary gland development. 
(a) Between embryonic days (E) 11.5 and 13.5 the mammary anlagen
develops from a small placode contiguous with the ectoderm into a
bud that invaginates the dermal mesenchyme (light gray). Rapid cell
proliferation at the base of the bud leads to the formation of an
elongated duct that grows toward the fat pad (intermediate gray
shading) on embryonic day 16.5. The mammary mesenchyme (dark
shading), which is induced by parathyroid hormone-related protein
(PTHrP) signals emanating from the mammary epithelium, abuts the
placode and bud and contributes to the formation of the nipple. 
(b) The stages of arrest in mammary gland development caused by the
different gene deletion mutants are indicated by bars. b, bud; ec,
ectoderm; ep, epidermis; n, nipple; p, placode; ps, primary sprout;
FGF, fobroblast growth factor.107
and other sites of tissue interactions, such as the limb bud
[10]. Mice with a targeted deletion of Tbx3 fail to develop
mammary glands and also display limb and yolk sac
deficiencies [11]. This signal appears to act at a very early
stage in mammary organogenesis as mammary buds and
localized expression of wnt10b and  Lef1 are absent in
Tbx3 knockout mice.
Parathyroid hormone-related protein (PTHrP), a small
peptide initially identified as the cause of humoral
hypercalemia of malignancies, is not only involved in the
regulation of calcium homeostasis, but also mediates the
formation of the primary mammary mesenchyme and
nipple sheath. PTHrP is expressed in the mammary bud,
and the receptor PTHR1 is expressed in the ventral
dermal mesenchyme [12]. Ectopic expression of PTHrP
by a keratin14 promoter-driven transgene leads to an
expansion of nipple skin and connective tissue over the
entire belly, demonstrating that PTHrP produced in the
epithelium induces a change in the differentiation of
dermal fibroblasts [13]. Genetic confirmation of the
absolute requirement of this signaling pathway for
mammary gland development comes from gene deletion
studies. Identical phenotypes, namely an arrest of
mammary gland development before outgrowth of the
primary sprout, occur upon targeted deletion of PTHrP or
the receptor PTHR1 [14]. A loss-of-function mutation in
the PTHR1 gene in humans causes Blomstrand chondro-
dysplasia, a rare, lethal form of dwarfism characterized by
defects in endochondral bone formation and the absence
of nipples and breasts [15].
In another instance, the combination of human and mouse
genetics has shed light on a previously unidentified signal
that affects mammary gland development. Mutations in
ectodysplasin (Eda), a member of the tumor necrosis
factor family, its receptor Edar and the Edar-binding death
domain adaptor protein Edaradd have been associated
with hypohidrotic ectodermal dysplasias, with mal-
formation of hair, teeth and sweat and with malformation of
exocrine glands. Expression of these molecules has not
been studied in detail in the mammary gland but, in
developing teeth and hair, Eda and  Edar are first
coexpressed in the simple ectodermal sheath before the
morphological appearance of placodes [16,17]. Their
expression patterns later become complementary; Eda is
downregulated in the placodes but remains high in the
adjacent ectoderm, and Edar expression persists in the
placodes. Furthermore, the expression of Eda is induced
by wnt via the Lef1 pathway. When Eda is ectopically
expressed from the keratin 14 promoter, supernumorary
nipples develop which are attached to a small ductal
system along the presumptive milk line [18]. Ectodysplasin
appears to mediate intraectodermal signals involved in
epithelial patterning rather than mediating signals from
one tissue to another.
Conclusions
These recent examples of the identification of novel
signaling mechanisms that direct mammary gland develop-
ment during the embryonic stage demonstrate a few
interesting points.
Some of the findings were clearly serendipitous and have
driven research into new directions. However, the
generation of mouse models of mutations associated with
defects in breast development in humans has taken a
more directed approach. There are more syndromes such
as the limb–mammary syndrome and the acro–dermato–
ungual–lacrimal–tooth syndrome, which have been
mapped to the p63 gene. The role of p63 has not been
thoroughly investigated in the context of mammary gland
development [19]. Interestingly, deletion of the p63 gene
in mice leads to inhibition of skin differentiation and a
complete absence of skin derivatives, as well as to
craniofacial and limb deformities [20,21]. This indicates
that p63 is critical for cell proliferation and/or
differentiation in tissues that depend on epithelial
mesenchymal interactions.
Second, none of the mutations so far identified are unique
to the mammary gland and there is no indication that only
one signal directs specification of the mammary
epithelium. Yet each mutation appears to affect different
appendages in distinct ways. This demonstrates that the
signals most probably activate downstream genes in cell-
specific contexts.
Finally some of the genes, such as PTHrP and Tbx3, are
upregulated in cancer. It remains to be determined
whether other signaling pathways that regulate cell
specification and proliferation, signaling between
epithelium and mesenchyme, cell migration and ductal
morphogenesis are also active in tumors. Understanding
their role in normal development may also influence our
thinking about regulatory processes in neoplastic
tissues.
While wnt signals seem to be crucial in the initial stages of
mammary development it is not yet clear whether the
different pathways that are active during these stages are
interconnected or independent of each other (Fig. 1b).
Careful comparison and staging of the developmental
arrests caused by the different mutants in conjunction with
expression analyses of specific markers (such as the
genes involved in wnt, FGF and Eda signaling) will be
required for the development of a cohesive model of the
genetic interactions among these pathways. Undoubtedly,
more genes will be discovered that play a role in early
mammary gland development and other ectoderm-derived
organs. Our challenge in the future will be to understand
these pathways, their interactions and the developmental
programs they activate.
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